SeaStar reports data from immunomodulator device study
The pilot study assessed the safety and efficacy of the SCD in Covid-19 ICU patients with multiple organ failure.

The pilot study assessed the safety and efficacy of the SCD in Covid-19 ICU patients with multiple organ failure.
The Omnipod 5 system significantly improved glycemic outcomes in children aged two to 5.9 years with type 1 diabetes.
AuriNovo is developed for surgical reconstruction of the outer ear in people who are born with microtia Grades II-IV.
The device deflects, captures and removes embolic particles while providing full-body embolic protection.
ADSCC will enrol 45 subjects for the clinical trial, which is designed to assess the efficacy and safety of ECP.
MidLantic Urology and ANGLE will start clinical studies to evaluate the Parsortix system in prostate cancer.
The AcetaSTAT rapid assay can detect blood markers for injury from an overdose of the drug in about 20 minutes.
The Vibrant System has been validated as a safe and well-tolerated option for addressing unmet treatment needs in CIC.
Thank you for subscribing to Medical Device Network